Constipation. Constipation
Conditions
Interventions
Intervention 1: Group 1: Polyethylene glycol (PEG) + placebo (n = 40). Intervention 2: Group 2: Probiotic + placebo (n = 40). Intervention 3: Group 3: polyethylene glycol (PEG) + probiotic (40).
Placebo
Treatment - Drugs
Group 1: Polyethylene glycol (PEG) + placebo (n = 40)
Group 2: Probiotic + placebo (n = 40)
Group 3: polyethylene glycol (PEG) + probiotic (40)
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 16 Years
Inclusion criteria
Inclusion criteria: nclusion criteria: children 2-16 years of age with chronic functional constipation associated with any disease.Exclusion criteria: Children diagnosed with IBS criteria ROME III;Treatment of constipation in the two weeks prior to study entry; Children with mental retardation or metabolic diseases (eg, hypothyroidism); Children with Hirschsprung's disease or anorectal anomalies injury or pathology; Children with a history of stomach or intestinal surgery; Children under medical treatment affecting the GI such as cisapride; Motilium, erythromycin and loperamide
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Defecation frequency per week. Timepoint: Baseline and then. Method of measurement: Questionnaire.;Stool consistency. Timepoint: Baseline and then. Method of measurement: Questionnaire.;Read Ndad having abdominal pain and painful defecation. Timepoint: Baseline and then. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: Baseline and then. Method of measurement: Checklist.;Nausea and vomiting. Timepoint: Baseline and then. Method of measurement: Checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarjan Habibi
Arak University of Medical Sciences
Outcome results
None listed